Keywords: two-year, data, biochem, pharma, 3tc, follow-on, results

Two-Year Data For BioChem Pharma's 3TC

Article | 09 October 1995

Print This

Follow-on results from BioChem Pharma's European Phase II/III trial of 3TC (lamivudine) in combination with Glaxo Wellcome's zidovudine have ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in